Remove Blogging Remove Report Remove Sample Remove Study
article thumbnail

Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects

Xconomy

A 20-patient Phase 1 study of an RNA drug discovered by Ionis Pharmaceuticals that is being tested as a treatment for Huntington’s disease by Roche was suspended after two reports of infections related to a device used to take samples of cerebral spinal fluid during the trial.

Sample 120
article thumbnail

Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years

Xconomy

The Obama administration’s push to sign up one million Americans for a long-term health study will start in New York, Pittsburgh, Chicago, and Tucson, AZ, top health officials said today. The VA is running its own long-term study with nearly half a million participants so far.).

Study 59